Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C24H40O4 |
| Molecular Weight | 392.572 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
InChI
InChIKey=RUDATBOHQWOJDD-BSWAIDMHSA-N
InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20-,22+,23+,24-/m1/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
300510
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
||
|
LOINC |
30519-3
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
||
|
NCI_THESAURUS |
C66913
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/14/1406
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
||
|
FDA ORPHAN DRUG |
175303
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
||
|
LOINC |
2065-1
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
||
|
FDA ORPHAN DRUG |
3384
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
||
|
LIVERTOX |
NBK547907
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
||
|
FDA ORPHAN DRUG |
235406
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
||
|
WHO-ATC |
A05AA01
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
||
|
WHO-VATC |
QA05AA01
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
474-25-9
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
0GEI24LG0J
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
36234
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
608
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
10133
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
4361
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
CHENODEOXYCHOLIC ACID
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
DB06777
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
0GEI24LG0J
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
CHEMBL240597
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
100000092597
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
m3324
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | Merck Index | ||
|
42588
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
ALTERNATIVE | |||
|
D002635
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
4391
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
DTXSID2020260
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
757798
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
SUB07463MIG
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
C65206
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
207-481-8
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
657949
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
16755
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY | |||
|
2323
Created by
admin on Wed Apr 02 08:46:26 GMT 2025 , Edited by admin on Wed Apr 02 08:46:26 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
PARENT (METABOLITE)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)